Comments
The stock of Dr Lal Path Labs (₹2,040.9) was trading flat for nearly a month. But last week, it gathered momentum and broke out of a key resistance at ₹2,000.
This has opened the door for further upside and the likelihood of the stock reaching ₹2,200 in the next couple of weeks is high. That said, we might see a minor decline where it could test the resistance-turned-support level of ₹2,000.
Trade strategy
Considering that the chance for a rally is high, we recommend buying a call option. Traders can go long on May expiry 2100-strike call option, which closed at ₹29.40.
The call option might not open exactly at ₹29.4 on Monday. Therefore, traders can have a range within which they can execute the order. We suggest buying 2100-call in the ₹25-30 price band. Add one more lot in case the price softens to ₹10. Thus, the average buy price would be between ₹18 and ₹20. Since the lot size of Dr Lal Path Labs’ derivative contract is 250 shares, buying two lots of call option would result in an outflow of about ₹10,000.
Since the capital outlay is on the lower side, traders can consider holding the call until expiry — till May 25. But before the expiration date, if the option premium rises to ₹40, exit one lot. Liquidate the remaining one lot when the price rises to ₹70.
Note: The recommendations are based on technical analysis and F&O positions. There is a risk of loss in trading
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.